» Articles » PMID: 23145206

Tumor-associated Macrophages: Function, Phenotype, and Link to Prognosis in Human Lung Cancer

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2012 Nov 13
PMID 23145206
Citations 219
Authors
Affiliations
Soon will be listed here.
Abstract

Macrophages are the dominant leukocyte population found in the tumor microenvironment. Accumulating evidence suggests that these tumor-associated macrophages (TAMs) actively promote all aspects of tumor initiation, growth, and development. However, TAMs are not a single uniform population; instead, they are composed of multiple distinct pro- and anti-tumoral subpopulations with overlapping features depending on a variety of external factors. Defining and differentiating these subsets remains a challenging work-in-progress. These difficulties are apparent in prognostic studies in lung cancer that initially demonstrated conflicting evidence regarding the significance of TAMs but which have more recently clarified and confirmed the clinical importance of these subsets through improved phenotypic capabilities. Thus, these cells represent potential targets for cancer therapeutic initiatives through translational approaches. In this review, we summarize the current understanding of how the tumor microenvironment takes advantage of macrophage plasticity to mold an immunosuppressive population, the phenotypic heterogeneity of TAMs, and their link to prognosis in human lung cancer.

Citing Articles

Targeting Cancer: Microenvironment and Immunotherapy Innovations.

Padzinska-Pruszynska I, Taciak B, Kiraga L, Smolarska A, Gorczak M, Kucharzewska P Int J Mol Sci. 2025; 25(24.

PMID: 39769334 PMC: 11679359. DOI: 10.3390/ijms252413569.


The expression of CCL17 and potential prognostic value on tumor immunity in thyroid carcinoma based on bioinformatics analysis.

Gu X, Chen B, Zhang S, Zhai X, Hu Y, Ye H Sci Rep. 2024; 14(1):31580.

PMID: 39738081 PMC: 11686015. DOI: 10.1038/s41598-024-75750-1.


Targeted SPP1 Inhibition of Tumor-Associated Myeloid Cells Effectively Decreases Tumor Sizes.

Kartal B, Garris C, Kim H, Kohler R, Carrothers J, Halabi E Adv Sci (Weinh). 2024; 12(4):e2410360.

PMID: 39639496 PMC: 11775521. DOI: 10.1002/advs.202410360.


Immune Response Modulation by HPV16 Oncoproteins in Lung Cancer: Insights from Clinical and In Vitro Investigations.

Sao Marcos B, Santos D, de Sousa G, Cruz L, Barros B, de Sena M Viruses. 2024; 16(11).

PMID: 39599846 PMC: 11599038. DOI: 10.3390/v16111731.


Proteomics and Bioinformatics Investigations Link Overexpression of FGF8 and Associated Hub Genes to the Progression of Ovarian Cancer and Poor Prognosis.

Kumar V, Tomar A, Thapliyal A, Yadav S Biochem Res Int. 2024; 2024:4288753.

PMID: 39309198 PMC: 11415250. DOI: 10.1155/2024/4288753.


References
1.
Raes G, Brys L, Dahal B, Brandt J, Grooten J, Brombacher F . Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation. J Leukoc Biol. 2004; 77(3):321-7. DOI: 10.1189/jlb.0304212. View

2.
Dai F, Liu L, Che G, Yu N, Pu Q, Zhang S . The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer. BMC Cancer. 2010; 10:220. PMC: 2880994. DOI: 10.1186/1471-2407-10-220. View

3.
Ojalvo L, Whittaker C, Condeelis J, Pollard J . Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J Immunol. 2009; 184(2):702-12. PMC: 3226722. DOI: 10.4049/jimmunol.0902360. View

4.
Chen J, Yao P, Yuan A, Hong T, Shun C, Kuo M . Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res. 2003; 9(2):729-37. View

5.
Balkwill F, Mantovani A . Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol. 2012; 22(1):33-40. DOI: 10.1016/j.semcancer.2011.12.005. View